Clinical Trial Update: Prospective Study of VEGFR-2 /IL-8 Genetic Interaction in MBC Treated With Paclitaxel and Bevacizumab vs. Chemotherapy

View source ↗

Summary

A prospective trial is examining how VEGFR-2 and IL-8 genetic interactions influence metastatic breast cancer outcomes when treated with paclitaxel and bevacizu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Avastin (bevacizumab)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: University of Pisa | Conditions: Metastatic Breast Cancer | Status: UNKNOWN